Regeneron Pharmaceuticals, Inc. director Christine A. Poon sells 7,830 shares worth $7.59M
An open-market sale on Nov 2, reported to the SEC on Nov 4, not marked as part of a 10b5-1 plan. Information only, not investment advice.
Insider selling at Regeneron Pharmaceuticals, Inc.: Christine A. Poon, a director, sold 7,830 shares on Nov 2 for $7.59 million, at an average of $969.09 a share, a Form 4 filed on Nov 4 shows.
The filing does not mark the sale as made under a Rule 10b5-1 trading plan. The insider still holds 5,219 shares after the sale, 60% fewer than before.
Three Regeneron Pharmaceuticals, Inc. insiders sold on the open market within 14 days, a pattern known as a cluster sell. The trade was reported within two business days, as Section 16 requires.
Details from the SEC filing:
| Company | Regeneron Pharmaceuticals, Inc. (REGN) |
|---|---|
| Insider | Christine A. Poon |
| Role | Director |
| Transaction | Open-market sale (code S) |
| Shares | 7,830 |
| Average price | $969.09 |
| Value | $7,587,958 |
| Trade date | Nov 2, 2026 |
| Filed with the SEC | Nov 4, 2026, 4:09 PM ET |
| Shares held after | 5,219 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
View this Form 4 in Insider Stock Trader
See the biggest insider trades of each day · Browse the latest insider selling
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
Related Articles
- Insider Trading News
Three Regeneron Pharmaceuticals, Inc. insiders sell $32.3M of stock within one day
- Insider Trading News
Regeneron Pharmaceuticals, Inc. insider George L. Sing sells $20.4M in REGN shares
- Insider Trading News
Regeneron Pharmaceuticals, Inc. officer Joseph J Larosa sells $4.31M in stock
- Insider Trading News
Insider buying and selling on Nov 4: Orbimed Advisors LLC leads with $15M
- Insider Trading News
Christine Ring, a chief legal officer at Nurix Therapeutics, Inc., sells $103,986 of stock
